Orphapacket:
  AverageAgeOfDeaths:
    AverageAgeOfDeath:
    - value: adult
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: All ages
  Childs:
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '7029'
            Source: HGNC
          - Reference: '164860'
            Source: OMIM
          Label: MET proto-oncogene, receptor tyrosine kinase
          Symbol: MET
      - Gene:
          ExternalReferences:
          - Reference: '2514'
            Source: HGNC
          - Reference: '116806'
            Source: OMIM
          Label: catenin beta 1
          Symbol: CTNNB1
      Label: Pediatric hepatocellular carcinoma
      ORPHAcode: '33402'
  - Child:
      Genes:
      - Gene:
          ExternalReferences:
          - Reference: '603816'
            Source: OMIM
          - Reference: '903'
            Source: HGNC
          Label: axin 1
          Symbol: AXIN1
      - Gene:
          ExternalReferences:
          - Reference: '8975'
            Source: HGNC
          - Reference: '171834'
            Source: OMIM
          Label: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit
            alpha
          Symbol: PIK3CA
      - Gene:
          ExternalReferences:
          - Reference: '1509'
            Source: HGNC
          - Reference: '601763'
            Source: OMIM
          Label: caspase 8
          Symbol: CASP8
      - Gene:
          ExternalReferences:
          - Reference: '11998'
            Source: HGNC
          - Reference: '191170'
            Source: OMIM
          Label: tumor protein p53
          Symbol: TP53
      - Gene:
          ExternalReferences:
          - Reference: '604584'
            Source: OMIM
          - Reference: '8805'
            Source: HGNC
          Label: platelet derived growth factor receptor like
          Symbol: PDGFRL
      - Gene:
          ExternalReferences:
          - Reference: '2514'
            Source: HGNC
          - Reference: '116806'
            Source: OMIM
          Label: catenin beta 1
          Symbol: CTNNB1
      - Gene:
          ExternalReferences:
          - Reference: '191092'
            Source: OMIM
          - Reference: '12363'
            Source: HGNC
          Label: TSC complex subunit 2
          Symbol: TSC2
      - Gene:
          ExternalReferences:
          - Reference: '12362'
            Source: HGNC
          - Reference: '605284'
            Source: OMIM
          Label: TSC complex subunit 1
          Symbol: TSC1
      - Gene:
          ExternalReferences:
          - Reference: '3229'
            Source: HGNC
          - Reference: '131530'
            Source: OMIM
          Label: epidermal growth factor
          Symbol: EGF
      Label: Adult hepatocellular carcinoma
      ORPHAcode: '210159'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377794
    value: Clinical group
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '114550'
    Source: OMIM
  Label: Hepatocellular carcinoma
  ORPHAcode: '88673'
  ORPHApacketId: '88673'
  PURL: http://www.orpha.net/ORDO/Orphanet_88673
  Parents:
  - Parent:
    - Label: Carcinoma of liver and intrahepatic biliary tract
      ORPHAcode: '424936'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001392
      HPOTerm: Abnormality of the liver
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001409
      HPOTerm: Portal hypertension
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002027
      HPOTerm: Abdominal pain
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002240
      HPOTerm: Hepatomegaly
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002904
      HPOTerm: Hyperbilirubinemia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003073
      HPOTerm: Hypoalbuminemia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0006707
      HPOTerm: Abnormality of the hepatic vasculature
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002034
      HPOTerm: Abnormality of the rectum
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002039
      HPOTerm: Anorexia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002040
      HPOTerm: Esophageal varix
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002910
      HPOTerm: Elevated hepatic transaminase
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003270
      HPOTerm: Abdominal distention
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0005293
      HPOTerm: Venous insufficiency
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0005978
      HPOTerm: Type II diabetes mellitus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0410019
      HPOTerm: Epigastric pain
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000952
      HPOTerm: Jaundice
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001541
      HPOTerm: Ascites
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001575
      HPOTerm: Mood changes
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001873
      HPOTerm: Thrombocytopenia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001894
      HPOTerm: Thrombocytosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001901
      HPOTerm: Polycythemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001903
      HPOTerm: Anemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001943
      HPOTerm: Hypoglycemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001945
      HPOTerm: Fever
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002014
      HPOTerm: Diarrhea
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002094
      HPOTerm: Dyspnea
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002480
      HPOTerm: Hepatic encephalopathy
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002605
      HPOTerm: Hepatic necrosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002653
      HPOTerm: Bone pain
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002664
      HPOTerm: Neoplasm
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002900
      HPOTerm: Hypokalemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002902
      HPOTerm: Hyponatremia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003072
      HPOTerm: Hypercalcemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004367
      HPOTerm: Abnormality of glycoprotein metabolism
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0004396
      HPOTerm: Poor appetite
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0010741
      HPOTerm: Pedal edema
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011029
      HPOTerm: Internal hemorrhage
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012050
      HPOTerm: Anasarca
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0025142
      HPOTerm: Constitutional symptom
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100762
      HPOTerm: Hemobilia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200114
      HPOTerm: Metabolic alkalosis
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002615
      HPOTerm: Hypotension
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0002639
      HPOTerm: Budd-Chiari syndrome
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0100523
      HPOTerm: Liver abscess
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 25142309[PMID]_SEER Surveillance Epidemiology and End Results 1973-2011[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2017[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22537432[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22537432[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Oceania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22537432[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Latin America
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22537432[PMID]_18666317[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12095924[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12095924[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12095924[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 6-9 / 10 000
      PrevalenceGeographic: Mongolia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 12095924[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 18666317[PMID]_20616577[PMID]_22537432[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  Synonyms:
  - Synonym: HCC
  TextSection:
    Contents: Hepatocellular carcinoma is a primary hepatic cancer derived from well-differentiated
      hepatocytes. It is more frequent in adults than in childhood. Symptoms are hepatic
      mass abdominal pain and in advanced stages jaundice cachexia and liver failure.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2022
  creationDate: '2022-11-28 11:04:13'
  version: 1.3.18 / 4.1.7 [2022-07-12] (orientdb version)
